Table 5. Means and standard deviations for items on self-evaluation scale performed before experiment (pre-treatment) and after the battery of tests (post-treatment).
Bodily Symptoms Scale (BSS) | Methylphenidate | F/H | P | ||||
---|---|---|---|---|---|---|---|
Placebo | 10 mg | 20 mg | 40 mg | ||||
Pre-Treatment | Physical exhaustion | 29.46 ± 22.57 | 20.57 ± 23.52 | 38.63 ± 29.62 | 29.53 ± 30.69 | 0.67 | 0.57 |
Headache | 5.13 ± 11 | 2.3 ± 3.54 | 1.42 ± 4.26 | 4.81 ± 11.76 | 0.41 | 0.74 | |
Dizziness | 10.14 ± 21.05 | 0.86 ± 1.83 | 10.82 ± 27.37 | 7.26 ± 13.67 | 0.53 | 0.65 | |
Trembling | 8.25 ± 15.13 | 6.89 ± 12.42 | 3.6 ± 6.99 | 4.99 ± 9.45 | 0.29 | 0.83 | |
Weakness | 9.15 ± 13.75 | 6.32 ± 10.37 | 0.86 ± 2.6 | 2.14 ± 3.74 | 5.05(H) | 0.16 | |
Muscular Tension | 19.5 ± 17.83 | 22.02 ± 21.65 | 6.71 ± 5.72 | 8.97 ± 20.88 | 1.64 | 0.19 | |
Nausea | 1.36 ± 4.08 | 1.29 ± 2.33 | 6.41 ± 19.23 | 1 ± 2.2 | 1.31(H) | 0.72 | |
Dry mouth | 51.05 ± 26.37 | 54.64 ± 35,52 | 59.82 ± 29.98 | 67 ± 26.52 | 0.48 | 0.69 | |
Sweat | 24.55 ± 31 | 21.1 ± 29.09 | 12.04 ± 17.27 | 11.83 ± 30.74 | 0.48 | 0.69 | |
Blurred vision | 31.67 ± 31.07 | 23.53 ± 29.79 | 24.78 ± 25.95 | 27.72 ± 24.66 | 0.15 | 0.92 | |
Palpitation | 4.57 ± 10.41 | 12.73 ± 16.29 | 13.32 ± 22.65 | 15.61 ± 29.06 | 0.48 | 0.69 | |
Difficulty breathing | 1.57 ± 3.14 | 7 ± 14.35 | 2.56 ± 5.43 | 0.67 ± 1.36 | 0.87(H) | 0.83 | |
Difficulty walking | 3.13 ± 6.99 | 2.42 ± 3.26 | 5.27 ± 15.81 | 0.82 ± 1.63 | 0.39 | 0.75 | |
Agitation | 25.62 ± 25.91 | 28.3 ± 27.58 | 28.86 ± 20.41 | 29.2 ± 27.89 | 0.03 | 0.99 | |
Motor Coordination | 90.67 ± 15.29 | 91.41 ± 10.83 | 91.29 ± 20.58 | 96.72 ± 8.48 | 0.33 | 0.79 | |
Hearing | 78.33 ± 39.23 | 95.38 ± 12.47 | 93.16 ± 20.51 | 99.13 ± 1.7 | 1.60(H) | 0.65 | |
Difficulty speaking | 17.01 ± 32.39 | 5.86 ± 7.92 | 1.99 ± 5.98 | 3.24 ± 7.13 | 3.31(H) | 0,34 | |
General wellbeing | 67,48 ± 38,46 | 92,23 ± 12,01 | 78,64 ± 32,56 | 90,88 ± 15,82 | 1,78(H) | 0,61 | |
Post-Treatment | Physical exhaustion | 45.21 ± 16.82 | 17.02 ± 24.1 | 39.37 ± 33.5 | 33.45 ± 19.61 | 2.24 | 0.10 |
Headache | 13.67 ± 24.32 | 8.92 ± 19.51 | 3.41 ± 8.13 | 0.85 ± 1.81 | 3.36(H) | 0.33 | |
Dizziness | 9.98 ± 23.87 | 9.65 ± 21.08 | 11.12 ± 28.18 | 2.84 ± 4.98 | 0.27 | 0.84 | |
Trembling | 10.11 ± 21.47 | 1,42 ± 1.75 | 3.16 ± 5.19 | 7.26 ± 15.26 | 0.12(H) | 0.98 | |
Weakness | 13.72 ± 22.27 | 7.99 ± 13.6 | 12.84 ± 28.32 | 6.55 ± 13.15 | 0.27 | 0.84 | |
Muscular Tension | 12.71 ± 15.66 | 27.15 ± 24.33 | 11.14 ± 11.52 | 15.82 ± 21.45 | 2.64(H) | 0.45 | |
Nausea | 2.85 ± 4.39 | 2.14 ± 2.13 | 7.12 ± 21.36 | 0 ± 0 | 6.79(H) | 0.07 | |
Dry mouth | 66.6 ± 29.31 | 69.33 ± 19.68 | 62.25 ± 29.79 | 71.71 ± 28.45 | 0.20 | 0.89 | |
Sweating | 9.02 ± 10.14 | 23.58 ± 33.77 | 19.97 ± 26.33 | 6.83 ± 20.51 | 3.65(H) | 0.30 | |
Blurred vision | 17.63 ± 23.88 | 31.58 ± 28.72 | 28.96 ± 21.68 | 28.71 ± 30.84 | 0.49 | 0.69 | |
Palpitation | 11.34 ± 20.66 | 20.58 ± 24.2 | 5.98 ± 16.55 | 16.09 ± 21.64 | 0.80 | 0.49 | |
Difficulty breathing | 7.12 ± 19.52 | 12.68 ± 22.29 | 4.7 ± 10.21 | 0 ± 0 | 6.74(H) | 0.08 | |
Difficulty walking | 9.98 ± 22.08 | 4.14 ± 7.18 | 6.12 ± 17.43 | 0.43 ± 1.3 | 0.67(H) | 0.57 | |
Agitation | 31.94 ± 29.54 | 30.44 ± 25.34 | 19.13 ± 20.93 | 30.53 ± 24.12 | 0.50 | 0.68 | |
Motor Coordination | 80.43 ± 21.62 | 83.13 ± 21.35 | 80.63 ± 24.83 | 89.74 ± 19.14 | 0.35 | 0.78 | |
Hearing | 92.42 ± 13.02 | 94.7 ± 6.78 | 86.03 ± 30.91 | 99.71 ± 0.86 | 4.10(H) | 0.25 | |
Difficulty speaking | 11.45 ± 17.93 | 8.43 ± 9.73 | 8.83 ± 26.01 | 0.56 ± 1.7 | 0.72 | 0.54 | |
General wellbeing | 64.3 ± 34.8 | 88.1 ± 11.73 | 88.45 ± 22.06 | 93.72 ± 15.72 | 8.52(H) | 0.03 |